Therapeutic Targeting of Type 2 Inflammation for the Treatment of Severe Asthma

Publisher： Bentham Science Publishers

ISSN： 2212-7038

Source： Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol.1, Iss.1, 2014-04, pp. : 2-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Airway Inflammation: Novel Therapies for the Treatment of Asthma

By  

Current Medicinal Chemistry, Vol. 13, Iss. 25, 2006-10 ,pp. : 3105-3111

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Kit Activation: A Potential Therapeutic Approach in the Treatment of Allergic Inflammation

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 1, 2007-03 ,pp. : 57-62

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Prostaglandin D2 Receptors DP and CRTH2 for Treatment of Inflammation

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 13, 2006-07 ,pp. : 1427-1444

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic treatment with heat-killed Mycobacterium vaccae (SRL172) in a mild and severe mouse model for allergic asthma

By Smit J.J.   Van Loveren H.   Hoekstra M.O.   Van der Kant P.A.A.   Folkerts G.   Nijkamp F.P.  

European Journal of Pharmacology, Vol. 470, Iss. 3, 2003-06 ,pp. : 193-199

Elsevier

Access to resources Recommend Favorite

The therapeutic potential of drugs targeting the arginase pathway in asthma

By Ricciardolo Fabio LM   Zaagsma Johan   Meurs Herman  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. : 1221-1231

Informa Healthcare

Access to resources Recommend Favorite